Hepatitis B Immunity Screen (Anti‑HBs Quantitative) in UAE | 550 AED | DHA Licensed

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Hospital‑Grade Home Collection with ISO‑Certified Cold‑Chain Transport and VIP Mobile Phlebotomy (8 AM – 11 PM).
Clinical Guidance: Complimentary Telephonic Post‑Test Result Interpretation by a DHA‑Licensed Clinical Advisor.
Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731 — instant confirmation.

Test Overview & Methodology

The Hepatitis B Immunity Screen (Anti‑HBs quantitative test) precisely measures the level of surface antibodies against the hepatitis B virus in your blood. This CLIA/CMIA platform delivers a single numerical result that tells you whether your immunity — from past vaccination or natural infection — is still protective.

Feature	Our Test (Anti‑HBs CLIA)	Closest Alternative (Qualitative Rapid Strip)
Precision	Quantitative IU/mL; CV < 5%	Qualitative (Positive/Negative only); subjective readout
Methodology	Chemiluminescent Immunoassay (CLIA/CMIA)	Lateral Flow Immunochromatography
Turnaround	Daily (same‑day report in most cases)	15–30 minutes, but often requires lab confirmation
UAE Regulatory	DHA/MOHAP Standardized, ISO 9001:2015	Variable; often no laboratory accreditation

Physician Insight & Safety Protocols

“This quantitative Anti‑HBs test is the gold standard for assessing immunity after hepatitis B vaccination or natural infection. A level above 10 IU/mL indicates protection in most individuals, but those on immunosuppressive therapy or with occupational exposure may require a higher threshold. Always share your result with your primary care physician to determine if a booster is needed.”
— Dr. Ajay Singh, DHA License 36234132, General Practitioner

Advisory Note

Do not modify or discontinue any prescribed antiviral, immunosuppressive, or other medication without consulting your treating physician. This test does not replace a full liver function evaluation or infectious disease consultation.

Exclusion Criteria & ER Red Flags

Do not proceed with home collection if:

Uncontrolled bleeding or anticoagulant therapy without physician clearance
Severe anemia (Hemoglobin < 7 g/dL)
Lack of legal capacity to consent (minors require guardian per Federal Decree‑Law No. 4 of 2016 on Medical Liability)
Active febrile illness >38.5°C

Seek emergency care if you experience:

Sudden jaundice, dark urine, or clay‑colored stools
Severe right‑upper‑quadrant pain or confusion
Unexplained bruising or bleeding
Signs of anaphylaxis after vaccination

Patient FAQ & Clinical Guidance

1. What does the Hepatitis B Immunity Screen measure, and how do I interpret the number?

A: The Hepatitis B Immunity Screen precisely quantifies anti‑HBs antibodies to confirm immune status and guide vaccination booster needs. Levels ≥10 IU/mL indicate protective immunity; values below 10 IU/mL suggest a booster dose, while results <5 IU/mL often require a complete revaccination series after clinical correlation.

2. Is a home blood draw safe and reliable for this in the UAE?

A: Our VIP mobile phlebotomy uses ISO‑certified cold‑chain transport, ensuring sample integrity identical to hospital collection standards. Every phlebotomist is DHA‑licensed, follows Federal Decree‑Law No. 4 of 2016 safety protocols, and the serum is processed within the stability window for CLIA technology.

3. How soon will I get my results, and who can explain them?

A: Daily TAT means most reports are delivered same‑day via secure link; we then offer complimentary telephonic guidance from a clinical advisor. This ensures you understand not only the numerical value but also the recommended vaccination timeline and any need for liver specialist referral.

UAE Regulatory & Data Privacy Adherence

Data Protection & Health Information Governance

DNA Labs UAE strictly complies with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical testing safety and patient consent procedures adhere to Federal Decree‑Law No. 4 of 2016 on Medical Liability. Our facility operates under DHA License No. 1143 at Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE.

Clinical & Logistical Metadata

Test Name	Hepatitis B Immunity Screen (Anti‑HBs Quantitative)
Price (AED)	550
Turnaround Time	Same day (daily processing)
Sample Type / Matrix	Serum or plasma (peripheral whole blood)
Methodology Used	Chemiluminescent Immunoassay (CLIA/CMIA)
ICD‑10‑CM Code	Z01.84 (Encounter for antibody response examination)
LOINC Code	22320-3 (Hepatitis B virus surface Ab [Units/volume] in Serum or Plasma)
DHA Facility License & Address	License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE